MIAMI, Aug. 03, 2023 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. FBIO (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will present a corporate overview at…Read More
Fortress Biotech to Present at the BTIG Virtual Biotechnology Conference 2023 Fortress Biotech NASDAQFBIO
